Choledocholithiasis laboratory findings

Choledocholithiasis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Choledocholithiasis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Choledocholithiasis laboratory findings On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Choledocholithiasis laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Choledocholithiasis laboratory findings
CDC on Choledocholithiasis laboratory findings
Choledocholithiasis laboratory findings in the news
Blogs on Choledocholithiasis laboratory findings
Directions to Hospitals Treating Choledocholithiasis
Risk calculators and risk factors for Choledocholithiasis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The laboratory data may be normal in as many as a thirds of patients with choledocholithiasis, and further evaluation of the Common bile duct is recommended by imaging studies to clarify the diagnosis.

Laboratory Findings

The laboratory data may be normal in as many as a third of patients with choledocholithiasis, and further evaluation of the Common bile duct is recommended by imaging studies to clarify the diagnosis.

• Elevated serum bilirubin and alkaline phosphatase reflect biliary obstruction, but these are neither highly sensitive nor specific for CBD stones.
• High Gamma-glutamyl transferase (GGT) level, greater than 90 U/L, has been suggested to be the most sensitive and specific indicator of CBD stones indicate a high risk of choledocholithiasis.